BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1105@pharmaconomics
DTSTAMP:20260707T021634Z
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270701
SUMMARY:RNAC PDUFA — Descartes-08 (estimated date)
DESCRIPTION:The FDA's approval decision on Descartes-08 for myasthenia gravis is due ~ Jun 30\, 2027. A green light opens the market\; a complete response letter (CRL) usually sinks the stock.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1453687/000145368726000087/pressrelease05262026.htm\n\nTrack it: https://pharmaconomics.com/e/1105
URL:https://pharmaconomics.com/e/1105
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:RNAC catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR